Home Page

AccuTool, CRISPR, CRISPR Cas9, CRISPR-Cas9, StarterKit, Starter Kit
SARS-CoV-2 mutations, SARS-CoV-2, COVID-19
mRNA, RNA, T7 RNA, T7 RNA Polymerase
Bioneer AccuLoader
Bioneer AccuLoader

AccuLoader

On February 25, 2021, BIONEER Corporation announced the launching of a new concept auxiliary device, “AccuLoader™,” designed to assist with the dispensation of samples and reagents to the correct wells and reduce the time spent on the sample preparation. 

AccuLoader™ is the world’s first patented precision auxiliary device developed by BIONEER Corporation. It can be applied to various molecular diagnostic tests, including COVID-19 tests. The device has a variety of functions ranging from scanning the information on a sample tube to automatically adjusting the position of the well for correct sample dispensation. It is also equipped with parts that aid in minimizing the chances of cross-contamination. Moreover, its dedicated mobile app, the “AccuLoader,” allows for managing and merging of all sample information collected from the same run.

For more information, please refer to our Press Release.

Copyright© 2020 BIONEER CORPORATION. All rights reserved.